Advocacy Actions
European Chamber Healthcare Equipment Working Group Rep. Presents “Buy China” policy issue at the EU Delegation to China
European Chamber Healthcare Equipment Working Group Rep. Presents “Buy China” policy issue at the EU Delegation to China
Read moreMeeting with the Centre for Medical Device Evaluation on the Technical Guideline of Methodological Comparison Techniques for In Vitro Diagnostic Reagent Exempted from Clinical Trials
On 9th October, the Centre for Medical Device Evaluation held a meeting on the Technical Guideline of Methodological Comparison Techniques for In Vitro Diagnostic Reagent Exempted from Clinical Trials.
Read moreComments to the Centre for Medical Device Evaluation on Further Specification of the Clinical Evaluation Section of eRPS
On 30th September, the medical devices sector submitted comments to the Centre for Medical Device Evaluation on further specification of the Clinical Evaluation Section of eRPS.
Advocacy Letter to the Healthcare Security Administration of Jiangsu Province on 'Volume-Based Procurement'
The Healthcare Equipment (HCE) Working Group sent an advocacy letter to the Healthcare Security Administration (HSA) of Jiangsu Province, asking to postpone the second round of 'volume-based procurement' of high-value consumable medical devices.
Read moreComments to the NMPA's Notice on Matters Related to the First Batch of Implementation of the Unique Device Identification of Medical Devices (Call for Comment)
On 25th September, the medical devices sector submitted comments to the National Medical Products Administration on the Notice on Matters Related to the First Batch of Implementation of the Unique Device Identification of Medical Devices (Call for Comment).
Read moreChinese-German Dialogue on Quality Infrastructure in the Field of Medical Devices
The Healthcare Equipment (HCE) Working Group participated in the Chinese-German Dialogue on Quality Infrastructure in the field of medical devices, co-organised by the German Federal Ministry for Economic Affairs and Energy (BMWi) and the Chinese National Medical Products Administration (NMPA).
Read moreCOCIR and HCE Members Contribute the 10th China International Medical Device Regulatory(CIMDR) Forum in Suzhou
As the co-supporter of the 10th China International Medical Device Regulatory (CIMDR) Forum in Suzhou, COCIR and several members of the Healthcare Equipment Working Groups attended the conference as the moderator and speaker for plenary and sub-forums.
Read moreMeeting with the Centre for Medical Device Evaluation of the National Medical Product Administration on the Regulations on Random Inspection of Medical Devices Quality (Draft for Comments)
On 23rd September. the Centre for Medical Device Evaluation of the National Medical Products Administration held a meeting on Regulations on Random Inspection of Medical Devices Quality (Draft for Comments).
Read moreComments to the NMPA's Regulations on Expansive Clinical Trial of Medical Devices
On 20th September, the medical devices sector submitted comments to the National Medical Products Administration on the Regulations on Expansive Clinical Trial of Medical Devices.
Read moreAdvocacy Letter to the State Administration for Market Regulation on Procurement Issue in Guangxi Province
On 20th September, the medical device sector sent an advocacy letter to the Antitrust Office of the State Administration for Market Regulation on procurement issue in Guangxi province.
Read more